Gastroenterology News and Research

RSS

Gastroenterology is the branch of medicine where the digestive system and its disorders are studied.

Treating ulcerative colitis and Crohn’s disease

Ulcerative colitis and Crohn’s disease are idiopathic (we don’t know the cause) inflammatory diseases (IBD) of the colon and/or small bowel. They are chronic in that we do not have a medical cure and are differentiated from IBS (irritable bowel syndrome) by inflammation that causes ulcerations of the GI tract.

7 Jul 2014

Forest Laboratories completes acquisition of Furiex Pharmaceuticals

Actavis plc today announced that its subsidiary Forest Laboratories, LLC has successfully completed its acquisition of Furiex Pharmaceuticals, Inc. in an all-cash transaction valued at approximately $1.1 billion, and up to approximately $360 million in a Contingent Value Right (CVR) that may be payable based on the status of eluxadoline, Furiex's lead product, as a controlled drug following approval.

2 Jul 2014

Children who undergo simple emergency surgeries on weekends are more likely to die

Children who undergo simple emergency surgeries, such as hernia repairs or appendix removals, on weekends are more likely to suffer complications and even die than children getting the same kind of treatment during the week, according to results of a Johns Hopkins Children's Center study.

1 Jul 2014

Actavis seeks FDA ANDA approval for generic Zubsolv, confirms patent challenge

Actavis plc today confirmed that it has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market Buprenorphine Hydrochloride and Naloxone Hydrochloride Dihydrate Sublingual Tablets, Eq, 1.4 mg/0.36 mg and 5.7 mg/1.4 mg Base. Actavis' ANDA product is a generic version of Orexo's Zubsolv, which is a partial opioid agonist indicated for the maintenance treatment of opioid dependence.

30 Jun 2014

Synthetic Biologics supports SYN-004 C.difficile preventative program with formation of Clinical Advisory Board

Synthetic Biologics, Inc., a developer of novel anti-infective biologic and drug candidates targeting specific pathogens that cause serious infections and diseases, announced today the formation of a Clinical Advisory Board (CAB) to support development of SYN-004, the Company's lead anti-infective product candidate for the prevention of the devastating effects of Clostridium difficile (C. difficile)

30 Jun 2014

Ferring Pharmaceuticals, Roche partner to make personalised infertility treatment possible

Ferring Pharmaceuticals and Roche have announced a collaboration to combine diagnostic testing technology from Roche with Ferring's human cell line derived recombinant follicle-stimulating hormone (human rFSH), a gonadotrophin currently in phase III development.

24 Jun 2014

Antiviral therapy can reduce risk of liver cancer in patients with chronic hepatitis B infection

One of the most severe complications of hepatitis B is the development of liver cancer, which is responsible for approximately 745,000 deaths worldwide each year.

24 Jun 2014

UEG calls for more nurse endoscopy workforce to reduce CRC deaths

Colorectal cancer (CRC) is currently estimated to claim the lives of 214,675[1] adults in Europe, equivalent to 1 death every 3 minutes.

20 Jun 2014

New clinical guidelines on diagnosis and management of idiosyncratic DILI

New clinical guidelines on the diagnosis and management of idiosyncratic drug-induced liver injury (DILI) appear in the July issue of The American Journal of Gastroenterology.

18 Jun 2014

Symbion and Surgery Partners sign definitive merger agreement

Surgery Center Holdings Inc. ("Surgery Partners" or "The Company"), a portfolio company of H.I.G. Capital, LLC ("H.I.G."), and Symbion Holdings Corporation ("Symbion"), a portfolio company of Crestview Partners, have announced that they have entered into a definitive merger agreement under which Surgery Partners will acquire 100% of the stock of Symbion for a total purchase price of $792 million.

16 Jun 2014

Dr Alenka Brooks scoops top prize for setting up Sheffield Women in Medicine network

A DOCTOR specialising in disorders of the digestive system has scooped a top national prize for helping set up an inspiring network championing the need for more women to get top positions in medicine and academia.

12 Jun 2014

Children's Hospital Los Angeles ranked among nation's top 5 again

For the third straight year, Children's Hospital Los Angeles is ranked among the top five children's hospitals in the country, a distinction that recognizes the hospital's clinical expertise and the quality and breadth of its patient care.

11 Jun 2014

African-American women at increased risk for deadlier breast cancers, study finds

A research study led by cancer specialists at MedStar Washington Hospital Center found that African-American women frequently present with biologically less favorable subtypes of breast cancer.

10 Jun 2014

Antiviral therapy may prevent hepatitis B virus from developing into hepatocellular carcinoma

Researchers have found that antiviral therapy may be successful in preventing hepatitis B virus from developing into the most common form of liver cancer, hepatocellular carcinoma (HCC).

9 Jun 2014

Infants exposed to bacterial species in house dust are less likely to develop asthma

Infants exposed to a diverse range of bacterial species in house dust during the first year of life appear to be less likely to develop asthma in early childhood, according to a new study published online on June 6, 2014, in the Journal of Allergy and Clinical Immunology.

9 Jun 2014

Probiotics effectively prevent hepatic encephalopathy in patients with cirrhosis of the liver

Probiotics are effective in preventing hepatic encephalopathy in patients with cirrhosis of the liver, according to a new study in Clinical Gastroenterology and Hepatology, the official clinical practice journal of the American Gastroenterological Association. Hepatic encephalopathy is a deterioration of brain function that is a serious complication of liver disease.

9 Jun 2014

Gastroenterology News and Research

Further Reading

Treating ulcerative colitis and Crohn’s disease

Forest Laboratories completes acquisition of Furiex Pharmaceuticals

Children who undergo simple emergency surgeries on weekends are more likely to die

Actavis seeks FDA ANDA approval for generic Zubsolv, confirms patent challenge

Synthetic Biologics supports SYN-004 C.difficile preventative program with formation of Clinical Advisory Board

Ferring Pharmaceuticals, Roche partner to make personalised infertility treatment possible

Antiviral therapy can reduce risk of liver cancer in patients with chronic hepatitis B infection

UEG calls for more nurse endoscopy workforce to reduce CRC deaths

New clinical guidelines on diagnosis and management of idiosyncratic DILI

Symbion and Surgery Partners sign definitive merger agreement

Dr Alenka Brooks scoops top prize for setting up Sheffield Women in Medicine network

Children's Hospital Los Angeles ranked among nation's top 5 again

African-American women at increased risk for deadlier breast cancers, study finds

Antiviral therapy may prevent hepatitis B virus from developing into hepatocellular carcinoma

Infants exposed to bacterial species in house dust are less likely to develop asthma

Probiotics effectively prevent hepatic encephalopathy in patients with cirrhosis of the liver

Blood oxygen sensor attached to endoscope identifies pancreatic cancer

Rice, MD Anderson researchers refine technique for attacking hard-to-reach tumors

SYNERA can help prevent needle stick pain associated with superficial IVs

Researchers find way to prevent nonalcoholic fatty liver disease

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News